| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 19, 2004
From Cardiovascular Disease in Women, Charite and Deutsches Herzzentrum Berlin (J.N., S.E., S.M., J.F., J.B., N.B., V.R.-Z); Charite and Deutsches Herzzentrum Berlin (R.H.); Klinik für Herz-, Gefäss- und Thoraxchirurgie, Deutsches Herzzentrum Berlin (H.R.Z., R.P.); and Institute for Medical Informatics, Biometry and Epidemiology, Charite (P.M.), Berlin, Germany. * To whom correspondence should be addressed. E-mail: zagrosek{at}dhzb.de.
Background--Estrogen receptor (ER)-mediated effects have been associated with the modulation of myocardial hypertrophy in animal models and in humans, but ER expression in the human heart and its relation to hypertrophy-mediated gene expression have not yet been analyzed. We therefore investigated sex- and disease-dependent alterations of myocardial ER expression in human aortic stenosis together with the expression of hypertrophy-related genes. Methods and Results--ER- Conclusions--ER-
Revised on August 21, 2004
Accepted on August 25, 2004
Upregulation of Myocardial Estrogen Receptors in Human Aortic Stenosis
Johannes Nordmeyer AS,
and -
, calcineurin A-
, and brain natriuretic peptide (BNP) mRNA were quantified by real-time polymerase chain reaction in left ventricular biopsies from patients with aortic valve stenosis (n=14) and control hearts with normal systolic function (n=17). ER protein was quantified by immunoblotting and visualized by immunofluorescence confocal microscopy. ER-
mRNA and protein were increased 2.6-fold (P=0.003) and 1.7-fold (P=0.026), respectively, in patients with aortic valve stenosis. Left ventricular ER-
mRNA was increased 2.6-fold in patients with aortic valve stenosis (P<0.0001). ER-
and -
were found in the cytoplasm and nuclei of human hearts. A strong inverse correlation exists between ER-
and calcineurin A-
mRNA in patients with aortic valve stenosis (r=-0.83, P=0.002) but not between ER-
or -
and BNP mRNA.
and -
in the human heart are upregulated by myocardial pressure load.
This article has been cited by other articles:
![]() |
S. Mahmoodzadeh, S. Fritschka, E. Dworatzek, T. H. Pham, E. Becher, A. Kuehne, M. M. Davidson, and V. Regitz-Zagrosek Nuclear Factor-{kappa}B Regulates Estrogen Receptor-{alpha} Transcription in the Human Heart J. Biol. Chem., September 11, 2009; 284(37): 24705 - 24714. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Kosloski, I. K. Bales, K. B. Allen, B. L. Walker, A. M. Borkon, R. S. Stuart, A. F. Pak, and M. J. Wacker Purification of cardiac myocytes from human heart biopsies for gene expression analysis Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H1163 - H1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Domingues-Montanari, I. Subirana, M. Tomas, J. Marrugat, and M. Senti Association between ESR2 Genetic Variants and Risk of Myocardial Infarction Clin. Chem., July 1, 2008; 54(7): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jazbutyte, P. A. Arias-Loza, K. Hu, J. Widder, V. Govindaraj, C. von Poser-Klein, J. Bauersachs, K.-H. Fritzemeier, C. Hegele-Hartung, L. Neyses, et al. Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats Cardiovasc Res, March 1, 2008; 77(4): 774 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liu, A. Deschamps, K. S. Korach, and E. Murphy Estrogen-Enhanced Gene Expression of Lipoprotein Lipase in Heart Is Antagonized by Progesterone Endocrinology, February 1, 2008; 149(2): 711 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Konhilas and L. A. Leinwand The Effects of Biological Sex and Diet on the Development of Heart Failure Circulation, December 4, 2007; 116(23): 2747 - 2759. [Full Text] [PDF] |
||||
![]() |
C. Bolego, E. Vegeto, C. Pinna, A. Maggi, and A. Cignarella Selective Agonists of Estrogen Receptor Isoforms: New Perspectives for Cardiovascular Disease Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2192 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jazbutyte, K. Hu, P. Kruchten, E. Bey, S. K.G. Maier, K.-H. Fritzemeier, K. Prelle, C. Hegele-Hartung, R. W. Hartmann, L. Neyses, et al. Aging Reduces the Efficacy of Estrogen Substitution to Attenuate Cardiac Hypertrophy in Female Spontaneously Hypertensive Rats Hypertension, October 1, 2006; 48(4): 579 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mahmoodzadeh, S. Eder, J. Nordmeyer, E. Ehler, O. Huber, P. Martus, J. Weiske, R. Pregla, R. Hetzer, and V. Regitz-Zagrosek Estrogen receptor alpha up-regulation and redistribution in human heart failure FASEB J, May 1, 2006; 20(7): 926 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schonfelder The biological impact of estrogens on gender differences in congestive heart failure Cardiovasc Res, September 1, 2005; 67(4): 573 - 574. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |